Nifedipine Tablet, Extended Release
Product Images NDC 50742-622

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 50742-622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image1 (Image 01)

Chemical structure of nifedipine, showing the molecular arrangement of atoms including methyl groups, nitro group, and aromatic ring typical of this dihydropyridine calcium channel blocker.*

FDA Label Image

Image2 (Image 02)

A data table showing mean reductions in trough supine blood pressure (systolic/diastolic) from two studies of nifedipine extended-release tablets. The table compares doses of 30 mg, 60 mg, and 90 mg with corresponding patient numbers and mean trough reductions in blood pressure, placebo response subtracted.*

FDA Label Image

Image3 (Image 03)

A table comparing the percentage of patients experiencing various adverse effects between nifedipine extended-release tablets (n=370) and placebo (n=126). Effects listed include headache, flushing/heat sensation, dizziness, fatigue/asthenia, nausea, and constipation, with corresponding percentages for each group.*

FDA Label Image

Image4 (Image 04)

Text panel listing nifedipine extended-release tablets with strengths 30 mg (yellow, marked Novast and 33), 60 mg (pink, marked Novast and 36), and 90 mg (brown, marked Novast and 39).*

FDA Label Image

Image5 (Image 05)

A data table displaying bottle size as 100 count for extended-release nifedipine tablets with strengths 30 mg, 60 mg, and 90 mg. Corresponding NDC codes are 50742-620-01, 50742-621-01, and 50742-622-01 respectively.*

FDA Label Image

Image6 (Image 06)

FDA Label Image

Image7 (Image 07)

Nifedipine Extended-Release Tablets, USP 30 mg, oral tablets by Ingenus Pharmaceuticals, LLC. The label states the product is Rx only and comes in a bottle of 100 tablets. Storage instructions specify to store at 20°-25°C and protect from light and moisture. Additional labeling includes the NDC 50742-620-01 and standard cautionary notes.*

FDA Label Image

Image8 (Image 08)

Nifedipine Extended-Release Tablets, USP 60 mg by Ingenus Pharmaceuticals, LLC. The label shows this Rx prescription oral tablet is extended-release and contains 100 tablets per container. It includes storage and handling instructions, an NDC number, barcodes, and manufacturer details.*

FDA Label Image

Image9 (Image 09)

Nifedipine Extended-Release Tablets, USP 90 mg oral tablets by Ingenus Pharmaceuticals, LLC. The label shows the drug is prescription only, with a package size of 100 tablets. The label includes storage instructions, a warning to protect from light and moisture, and instructions that tablets should be swallowed whole.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.